Abstract
Purpose: Our purpose was to assess the value of monitoring serum P and inhibin A to determine how values might improve the clinical monitoring of natural cycle in vitro fertilization (IVF)-embryo transfer (ET) patients.
Methods: All patients (n = 26) who underwent natural-cycle IVF-ET (n = 35) were analyzed. Groups were evaluated according to patients who had a spontaneous luteinizing hormone (LH) surge (group I) and women receiving human chorionic gonadotropin (hCG) who underwent subsequent oocyte aspiration (group II). Group II was further evaluated according to women who did (n = 10) and did not (n = 7) have an ET. All cycles were evaluated with serial transvaginal ultrasonography and serum estradiol, progesterone, and inhibin A. When follicle maturity was achieved, hCG, 10,000 IU, was administered intramuscularly if a LH surge was not detected. Transvaginal ultrasound-guided aspiration was performed 34–36 hr after hCG administration followed by a 48-hr transcervical ET.
Results: No differences were seen in cycles the day prior to (d-1) and the day of a spontaneous LH surge, (n = 18) or hCG (d-0)(n = 17) in group I or group II with respect to lead follicular diameter (d-1,15.3 ± 0.6 vs. 14.2 ± 0.9 mm; d-0, 17.4 ± 0.8 vs. 17.8 ± 0.6 mm) and serum estradiol (d-l, 148 ± 15 vs. 150 ± 15 pg/ml; d-0, 218 ± 15 vs. 199 ± 16 pg/ml), respectively. However, serum progesterone was significantly elevated in group I compared with group II on d-l (0.82 ± 0.6 vs. 0.48 ± 0.04 ng/ml; P < 0.05) and d-0 (1.1 ± 0.12 vs. 0.63 ± 0.08 ng/ml; P < 0.05). Inhibin A was significantly greater on d-l in group I (24 ± 2.5 vs. 15 ± 2.2 pg/ml; P < 0.05). In group II, cycles that resulted in an ET (n = 10) compared with group II cycles that did not (n = 7) revealed a significant difference in serum progesterone (0.51 ± 0.05 vs. 0.7 ± 0.07 ng/ml; P < 0.05) and inhibin A (15 ± 2.5 vs. 37.3±5 pg/ml; P < 0.05) the day of hCG.
Conclusions: The possible application of serum progesterone and inhibin A in managing natural-cycle IVF-ET is suggested. These assays may predict women who should be set up for egg retrieval, while canceling others in spite of the absence of an LH surge.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Edwards RG, Steptoe PC, Purdy JM: Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 1980;87:737-756
Paulson RJ, Marrs RP: Ovulation stimulation and monitoring for in vitro fertilization. Curr Probl Obstet Gynecol Fertil 1986;9:497-526
Fossum GT, Davidson A, Paulson RJ: Ovarian hyperstimulation inhibits embryo implantation in the mouse. J In Vitro Fert Embryo Transfer 1989;6:7-10
Paulson RJ, Sauer MV, Francis MM, Macaso TM, Lobo RA: In vitro fertilization in unstimulated cycles: A clinical trial using hCG for timing of follicle aspiration. Obstet Gynecol 1990;76:788-791
Foulot H, Ranoux C, Dubuisson JB, Rambaud D, Aubriot FX, Poirot C: In vitro fertilization without ovarian stimulation: A simplified protocol applied in 80 cycles. Fertil Steril 1989;52:617-621
Medical Research International and the American Fertility Society Special Interest Group: In vitro fertilization/embryo transfer in the United States: 1990 results from the National IVF/ET Registry. Fertil Steril 1992;57:15-24
Society for Assisted Reproductive Technology: Assisted reproductive technology in the United States: 1993 results for assisted reproductive technology generated from the American Fertility Society registry. Fertil Steril 1995;64:13-21
Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton W, Huynh D: Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51:455-459
Goodman AL, Hodgen GD: The ovarian triad of the primate menstrual cycle. Recent Prog Horm Res 1983;39:1-73
Hoff JD, Quigley ME, Yen SSC: Hormonal dynamics at midcycle: A reevaluation. J Clin Endocrinol Metab 1983;57:792-796
Ying S-Y: Inhibins, activins, and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988;9:267-293
Miller PB, Soules MR: The usefulness of a urinary LH kit for ovulation prediction during menstrual cycles of normal women. Obstet Gynecol 1996;87:13-17
McLachlan RI, Robertson DM, Healy DL, et al.: Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab 1987;65:954-961
Paulson RJ, Sauer MV, Francis MM, Macaso TM, Lobo RA: In vitro fertilization in unstimulated cycles: The University of Southern California experience. Fertil Steril 1992;57:290
Lindheim SR, Sauer MV, Francis MM, Macaso TM, Lobo RA, Paulson RJ: The utility of a midcycle FSH boost in addition to HCG for timing of follicle aspiration in unstimulated IVF cycles. Gynecol Obstet Invest 1997;43:76-78
Paulson RJ, Sauer MV, Lobo RA: Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: Physiologic observations and preliminary experience. J Assist Reprod Genet 1994;11:28-32
Seibel MM, Kearnan M, Kiessling A: Parameters that predict success for natural cycle in vitro fertilization-embryo transfer. Fertil Steril 1995;63:1251-1254
Claman P, Domingo M, Garner P, Leader A, Spence JEH: Natural cycle in vitro fertilization-embryo transfer at the University of Ottawa: An inefficient therapy for tubal infertility. Fertil Steril 1993;60:298-302
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindheim, S.R., Chang, P.L., Vidali, A. et al. The Utility of Serum Progesterone and Inhibin A for Monitoring Natural-Cycle IVF-ET. J Assist Reprod Genet 15, 538–541 (1998). https://doi.org/10.1023/A:1022530103330
Issue Date:
DOI: https://doi.org/10.1023/A:1022530103330